The effect of chronic dental inflammation on development of Stage 0 medication-related osteonecrosis of the jaw

---

Copy For Citation

TOPALOĞLU G., KÖSEOĞLU O. T., KARACA Ç., KÖSEMEHMETOĞLU K.

JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, vol.45, no.8, pp.1158-1164, 2017 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 45 Issue: 8
• Publication Date: 2017
• Doi Number: 10.1016/j.jcms.2017.05.003
• Journal Name: JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.1158-1164
• Keywords: MRONJ, Bisphosphonate, Anti-resorptive drug, CTX, Osteonecrosis, BISPHOSPHONATE-RELATED OSTEONECROSIS, SURGEONS POSITION PAPER, RISK-FACTORS, CANCER-PATIENTS, ZOLEDRONIC ACID, AMERICAN ASSOCIATION, PREVENTIVE MEASURES, TOOTH EXTRACTION, BONE METASTASES, IMPLEMENTATION
• Hacettepe University Affiliated: Yes

Abstract

Objective: The pathogenesis of medication-related osteonecrosis of jaw (MRONJ) is poorly understood. The aim of this prospective study was to determine the effect of chronic dental inflammation on the development of Stage 0 MRONJ based on histopathological findings.